Prevention of Conversion in Posterior Retroperitoneal Adrenalectomy by Measuring Preoperative Anatomical Conditions

NCT04071561 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 14

Last updated 2019-08-28

No results posted yet for this study

Summary

With our retrospective study the investigators show the limitations of the posterior retroperitoneal adrenalectomy by analyzing anatomical parameters.

The investigators compared the data from one patient who underwent a conversion with 13 patients without a conversion. Furthermore, they explored the influence of these parameters on the operation time and excluded the patient who had a conversion from this analysis.

The investigators hypothesize that by determining anatomical characteristics on cross-sectional imaging (CT or MRI), they can show the limitations of the posterior retroperitoneal adrenalectomy to prevent patients from being converted to lateral transperitoneal adrenalectomy.

Conditions

  • Adrenal Tumor
  • Adrenal Mass
  • Pheochromocytoma
  • Conn Adenoma
  • Adrenal Metastases
  • Adrenal Hyperplasia

Interventions

OTHER

Posterior retroperitoneal adrenalectomy (PRA)

Minimally invasive adrenalectomy procedure

OTHER

Lateral transperitoneal adrenalectomy (LTA)

During posterior retroperitoneal adrenalectomy, the failure to progress or the difficulty of creating or maintaining a pneumoperitoneum are reasons why conversion occurs.

Sponsors & Collaborators

  • Kantonsspital Aarau

    collaborator OTHER
  • University of Basel

    lead OTHER

Principal Investigators

  • Christian A Nebiker, PD Dr. med. · Kantonsspital Aarau

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-19
Primary Completion
2019-05-31
Completion
2019-05-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04071561 on ClinicalTrials.gov